The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Financial Times highlights include BP's reduced bonus payout, Entain's CEO stepping down, Novartis' acquisition of Anthos Therapeutics, and EU's planned retaliation against US tariffs on steel and ...

The pharmaceutical giant said it has agreed to acquire the U.S. privately held, clinical-stage biopharmaceutical company to ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

British homeware retailer Dunelm Group said on Tuesday that Chief Executive Officer Nick Wilkinson has decided to retire from the company after serving seven years in the role.

Schaffert said: "Becoming CEO of Novartis Oncology is a great honour and I am humbled to be given the opportunity to lead one of the top-tier oncology businesses in the world.

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Top agency executives weigh in on the smartest, most impactful and effective commercials to reach Super Bowl LIX viewers as ...

Most of the commercials airing during this year's Super Bowl are going for laughs, with advertisers betting that America ...

Nestle's slumping share price is rattling shareholders and pension funds that have invested in the food giant, piling ...